PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In those already diagnosed with NAFLD, it may be beneficial to take into account the PNPLA3 genetic variant in individualizing surveillance, as it may be more influential in progression to NAFLD‐related hepatic fibrosis than environmental factors.